NCT06722794Completed
Fixating the Plate of Ahmed Valve to the Sclera Using a Flanged Prolene Suture
Novel Technique for Fixating the Plate of Ahmed Valve to the Sclera Using a Single Flanged Prolene Suture
Source: ClinicalTrials.gov · Last updated 9 Dec 2024
Brief summary (registry, in English)
this study evaluated new technique for suturing the Ahmed valve device used to treat resistant types of glaucoma
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 40 (actual)
- First submitted
- 2 Dec 2024
- Start date
- 1 Jun 2024
- Primary completion date
- 31 Oct 2024
- Lead sponsor
- Zagazig University
- Diseases
- Glaucoma
- NCT number
- NCT06722794
What you commit to
- Study type: Interventional
- Participants enrolled: 40
- From 1 Jun 2024 to the primary completion date, 31 Oct 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- The exclusion criteria were as follows: patients below 18 years old, those with active uveitis and angle closure glaucoma patients.
Who the study is looking for
- Patients with IOP more than 21 mmHg , evidence of progressive optic nerve damage, retinal nerve fiber layer defects or typical glaucomatous visual field defects despite maximal tolerable medical or laser treatment are scheduled for surgery.
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Maghrabi Eye Hospitals Coordinator of this site? Confirm its status | Jeddah | Saudi Arabia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.